Stock Analysis
- Qatar
- /
- Healthcare Services
- /
- DSM:MCGS
Medicare Group Q.P.S.C First Quarter 2024 Earnings: EPS: ر.ق0.07 (vs ر.ق0.07 in 1Q 2023)
Medicare Group Q.P.S.C (DSM:MCGS) First Quarter 2024 Results
Key Financial Results
- Revenue: ر.ق130.1m (up 1.6% from 1Q 2023).
- Net income: ر.ق19.8m (up 5.1% from 1Q 2023).
- Profit margin: 15% (in line with 1Q 2023).
- EPS: ر.ق0.07 (in line with 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Medicare Group Q.P.S.C shares are down 3.6% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Medicare Group Q.P.S.C has 2 warning signs we think you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Medicare Group Q.P.S.C is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About DSM:MCGS
Medicare Group Q.P.S.C
Medicare Group Q.P.S.C. provides healthcare and treatment services in Qatar.
Excellent balance sheet and slightly overvalued.